Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:13:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov page, linking to transition updates and explaining that “Super Intelligence” is replacing “Artificial Intelligence” in federal agency content.
    Difference
    1%
    Check dated 2026-10-25T15:26:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:50:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:31.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Access to the study record page now shows a 403 Forbidden error, replacing the expected content. This indicates the record is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T20:30:07.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract notes for 2019 and 2023. The page shows an updated revision tag, Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T06:16:55.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.